Poly(amidoamine) dendrimer–drug conjugates with disulfide linkages for intracellular drug delivery

Lee, 2005, Designing dendrimers for biological applications, Nat Biotechnol, 23, 1517, 10.1038/nbt1171 Svenson, 2005, Dendrimers in biomedical applications & reflections on the field, Adv Drug Deliv Rev, 57, 2106, 10.1016/j.addr.2005.09.018 Esfand, 2001, Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications, Drug Discov Today, 6, 427, 10.1016/S1359-6446(01)01757-3 Duncan, 2005, Dendrimer biocompatibility and toxicity, Adv Drug Deliv Rev, 57, 2215, 10.1016/j.addr.2005.09.019 Sato, 2001, Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores, Magn Reson Med, 46, 1169, 10.1002/mrm.1314 Malik, 2000, Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo, J Control Release, 65, 133, 10.1016/S0168-3659(99)00246-1 Matsumura, 1986, A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumour agent, Cancer Res, 46, 6387 Kukowska-Latallo, 2005, Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer, Cancer Res, 65, 5317, 10.1158/0008-5472.CAN-04-3921 Malik, 1999, Dendrimer–platinate: a novel approach to cancer chemotherapy, Anticancer Drugs, 10, 767, 10.1097/00001813-199909000-00010 Zhuo, 1999, In vitro release of 5-fluorouracil with cyclic core dendritic polymer, J Control Release, 57, 249, 10.1016/S0168-3659(98)00120-5 Gurdag, 2006, Activity of dendrimer–methotrexate conjugates on methotrexate-sensitive and -resistant cell lines, Bioconjug Chem, 17, 275, 10.1021/bc0501855 Lee, 2006, A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas, Proc Natl Acad Sci U S A, 103, 16649, 10.1073/pnas.0607705103 Wiwattanapatapee, 2003, Dendrimers conjugates for colonic delivery of 5-aminosalicylic acid, J Control Release, 88, 1, 10.1016/S0168-3659(02)00461-3 Kolhe, 2006, Preparation, cellular transport, and activity of polyamidoamine-based dendritic nanodevices with a high drug payload, Biomaterials, 27, 660, 10.1016/j.biomaterials.2005.06.007 Najlah, 2006, Synthesis, characterization and stability of dendrimer prodrugs, Int J Pharm, 308, 175, 10.1016/j.ijpharm.2005.10.033 Khandare, 2005, Cellular transport, and activity of polyamidoamine dendrimer–methylprednisolone conjugates, Bioconjug Chem, 16, 330, 10.1021/bc0498018 Navath, 2008, Dendrimers–drug conjugates for tailored intracellular drug release based on glutathione levels, Bioconjug Chem, 19, 2446, 10.1021/bc800342d Zafarullah, 2003, Molecular mechanisms of N-acetyl cysteine actions, Cell Mol Life Sci, 60, 6, 10.1007/s000180300001 Khan, 2004, Administration of N-acetyl cysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke, J Neurosci Res, 4, 519, 10.1002/jnr.20087 Dekhuijzen, 2004, Antioxidant properties of N-acetyl cysteine: their relevance in relation to chronic obstructive pulmonary disease, Eur Respir J, 23, 629, 10.1183/09031936.04.00016804 Harada, 2002, Kinetic analysis of covalent binding between N-acetyl-l-cysteine and albumin through the formation of mixed disulfides in human and rat serum in vitro, Pharm Res, 19, 1648, 10.1023/A:1020749211745 Yip, 1998, Intravenous administration of oral N-acetyl cysteine, Crit Care Med, 26, 40, 10.1097/00003246-199801000-00014 Kannan RM, Iezzi R, Rajaguru B, Kannan S. Dendrimer-containing particles for sustained release of compounds. International Patent Application Number: PCT/US2008/078988; 2007. Kolhe, 2003, Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers, Int J Pharm, 259, 143, 10.1016/S0378-5173(03)00225-4 Patri, 2005, Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex, Adv Drug Deliv Rev, 57, 2203, 10.1016/j.addr.2005.09.014 De Jesus, 2002, Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation, Bioconjug Chem, 13, 453, 10.1021/bc010103m Bracci, 2003, Synthetic peptides in the form of dendrimers become resistant to protease activity, J Biol Chem, 278, 46590, 10.1074/jbc.M308615200 Meister, 1983, Glutathione, Annu Rev Biochem, 52, 711, 10.1146/annurev.bi.52.070183.003431 Arrick, 1984, Glutathione metabolism as a determinant of therapeutic efficacy: a review, Cancer Res, 44, 4224 Saito, 2003, Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities, Adv Drug Deliv Rev, 55, 199, 10.1016/S0169-409X(02)00179-5 Zhang, 2003, Evaluation of multivalent dendrimers based on melamine: kinetics of thiol–disulfide exchange depends on the structure of the dendrimer, J Am Chem Soc, 25, 5086, 10.1021/ja0210906 Cuchelkar, 2008, Synthesis and biological evaluation of disulfide-linked HPMA copolymer–mesochlorin e6 conjugates, Macromol Biosci, 8, 375, 10.1002/mabi.200700240 Saadani-Makki, 2008, Intrauterine administration of endotoxin leads to motor deficits in a rabbit model: a link between prenatal infection and cerebral palsy, Am J Obstet Gynecol, 199, 651, 10.1016/j.ajog.2008.06.090 Roy, 2008, Reactive oxygen species up-regulate CD11b in microglia via nitric oxide: implications for neurodegenerative diseases, Free Radic Biol Med, 45, 686, 10.1016/j.freeradbiomed.2008.05.026 Winterbourn, 1999, Reactivity of biologically important thiol compounds with superoxide and hydrogen peroxide, Free Radic Biol Med, 27, 322, 10.1016/S0891-5849(99)00051-9 Perumal, 2008, The effect of surface functionality on cellular trafficking of dendrimers, Biomaterials, 29, 3469, 10.1016/j.biomaterials.2008.04.038 Kitchens, 2007, Endocytosis and interaction of poly(amidoamine) dendrimers with caco-2 cells, Pharm Res, 24, 2138, 10.1007/s11095-007-9415-0 Min, 2003, Plasminogen-induced IL-1beta and TNF-alpha production in microglia is regulated by reactive oxygen species, Biochem Biophys Res Commun, 312, 969, 10.1016/j.bbrc.2003.11.010 Flora, 2004, Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetyl cysteine during chelation with succimer in male rats, Cell Mol Biol, 50, 543 Paintlia, 2008, Lipopolysaccharide-induced peroxisomal dysfunction exacerbates cerebral white matter injury: attenuation by N-acetyl cysteine, Exp Neurol, 210, 560, 10.1016/j.expneurol.2007.12.011